Sam Brusco, Associate Editor08.11.22
Levita Magnetics has closed a $26 million Series C financing round. The funds will be used to support regulatory and commercial efforts in the U.S. for its Magnetic-Assisted Robotic Surgery (MARS) platform.
MARS’ benefits build on the company’s flagship Levita Magnetic Surgical System, including less pain, faster recovery, and fewer scars. It also touts improved visualization, enhanced instrument control, and fewer assistive personnel needed for procedures.
Its compact footprint is designed for outpatient or same-day discharge procedures in high-volume abdominal surgeries. To date, over 30 cases has been performed using the Levita Robotic Platform in a clinical trial in Chile, including sleeve gastrectomies and ambulatory cholecystomies.
“We are thrilled to have the support of this premier group of forward-thinking investors as we take the company to the next level with our unique approach to surgical robotics,” Dr. Alberto Rodriguez-Navarro, surgeon, founder and CEO of Levita Magnetics told the press. “At Levita, we believe that everyone deserves the benefits of MARS, offering the potential for less pain, faster recovery, and less scarring. Our platform is poised to address the worldwide problem of limited access to better robotic surgery.”
MARS’ benefits build on the company’s flagship Levita Magnetic Surgical System, including less pain, faster recovery, and fewer scars. It also touts improved visualization, enhanced instrument control, and fewer assistive personnel needed for procedures.
Its compact footprint is designed for outpatient or same-day discharge procedures in high-volume abdominal surgeries. To date, over 30 cases has been performed using the Levita Robotic Platform in a clinical trial in Chile, including sleeve gastrectomies and ambulatory cholecystomies.
“We are thrilled to have the support of this premier group of forward-thinking investors as we take the company to the next level with our unique approach to surgical robotics,” Dr. Alberto Rodriguez-Navarro, surgeon, founder and CEO of Levita Magnetics told the press. “At Levita, we believe that everyone deserves the benefits of MARS, offering the potential for less pain, faster recovery, and less scarring. Our platform is poised to address the worldwide problem of limited access to better robotic surgery.”